Skip to main content
Year archive

Spyre Therapeutics, Inc. — 2026 filings

All 22 regulatory filings released by Spyre Therapeutics, Inc. (SYRE) in 2026, sourced directly from the official regulator.

22 Filings
2026 Period
2026 filings (22)
Filing Released Lang
8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)
Regulatory Filings
2026-05-05 English
10-Q - Spyre Therapeutics, Inc. (0001636282) (Filer)
Interim / Quarterly Report
2026-05-05 English
8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)
Regulatory Filings
2026-04-16 English
424B5 - Spyre Therapeutics, Inc. (0001636282) (Filer)
Regulatory Filings
2026-04-13 English
8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)
Regulatory Filings
2026-04-13 English
8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)
Regulatory Filings
2026-04-13 English
DEF 14A - Spyre Therapeutics, Inc. (0001636282) (Filer)
Proxy Solicitation & Information Statement
2026-04-10 English
SCHEDULE 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - SPYRE THERAPEUTICS, INC. (0001636282) (Filer)
Director's Dealing
2026-03-04 English
4 - SPYRE THERAPEUTICS, INC. (0001636282) (Filer)
Director's Dealing
2026-03-04 English
S-3 - SPYRE THERAPEUTICS, INC. (0001636282) (Filer)
Regulatory Filings
2026-02-19 English
8-K - SPYRE THERAPEUTICS, INC. (0001636282) (Filer)
Regulatory Filings
2026-02-19 English
10-K - SPYRE THERAPEUTICS, INC. (0001636282) (Filer)
Annual Report FY 2025
2026-02-19 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
4 Filing
Director's Dealing
2026-02-04 English
4 Filing
Director's Dealing
2026-01-23 English
FORM 4
Director's Dealing
2026-01-14 English
FORM 4
Director's Dealing
2026-01-14 English
FORM 4
Director's Dealing
2026-01-14 English
FORM 4
Director's Dealing
2026-01-14 English
8-K
Regulatory Filings
2026-01-12 English
FORM 4
Director's Dealing
2026-01-07 English